RMgmDB - Rodent Malaria genetically modified Parasites

Back to search results

Summary

RMgm-1419
Malaria parasiteP. berghei
Genotype
TaggedGene model (rodent): PBANKA_1311700; Gene model (P.falciparum): PF3D7_1447900; Gene product: multidrug resistance protein 2 | ABC transporter B family member 2 (MDR2; ABCB2)
Name tag: mCherry-3xMyc
Transgene
Transgene not Plasmodium: GFP
Promoter: Gene model: PBANKA_0711900; Gene model (P.falciparum): PF3D7_0818900; Gene product: heat shock protein 70 (HSP70)
3'UTR: Gene model: PBANKA_1340000; Gene product: dihydrofolate synthase/folylpolyglutamate synthase, putative (PbDHFS-FPGS)
Replacement locus: Gene model: PBANKA_1311700; Gene product: multidrug resistance protein 2; ABC transporter B family member 2 (MDR2; ABCB2)
Phenotype Asexual bloodstage; Gametocyte/Gamete; Fertilization and ookinete; Oocyst; Sporozoite;
Last modified: 5 April 2016, 11:22
  *RMgm-1419
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene tagging, Introduction of a transgene
Reference (PubMed-PMID number) Reference 1 (PMID number) : 26991313
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei ANKA cl15cy1
Other information parent lineA reference wild type clone from the ANKA strain of P. berghei (PubMed: PMID: 17406255).
The mutant parasite was generated by
Name PI/ResearcherRijpma SR, Janse CJ, Franke-Fayard BM
Name Group/DepartmentLeiden Malaria Research Group
Name InstituteLeiden University Medical Center (LUMC)
CityLeiden
CountryThe Netherlands
Name of the mutant parasite
RMgm numberRMgm-1419
Principal namePbMDR2::mCherry
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageExpression of PbMDR2::mCherry in blood stages
Gametocyte/GameteExpression of PbMDR2::mCherry in gametocytes
Fertilization and ookineteExpression of PbMDR2::mCherry in ookinetes
OocystWeak expression of PbMDR2::mCherry in oocysts
SporozoiteWeak expression of PbMDR2::mCherry in sporozoites
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
The mutant expresses a C-terminal mCherry-3xMyc tagged version of MDR2 and expresses GFP under control of the constitutive HSP70 promoter

Protein (function)
In different Plasmodium parasites 14-16 ABC-transporter genes have been identified (16 in P. falciparum, 14 in P. berghei). Based on phylogenetic analysis of the conserved nucleotide-binding domains, seven of these are recognized as members of the B family of ABC transporters (both in P. falciparum and in P. berghei). This includes MDR2.

Phenotype
See also mutants RMgm-1165 and RMgm-1166 that lack expression of MDR2. These mutants show decreased oocyst and sporozoite production.

The mutant expressing tagged MDR2 showed normal development throughout the complete life cycle indicating that the mCherry-3xMyc tag did not affect the function of MDR2.

Expression of PbMDR2::mCherry was observed in blood stages and in ookinetes. Weak expression was observed in oocysts and sporozoites.

In  both  asexual  blood  stages  and  gametocytes  of  Pbmdr2::mCherry  fluorescence  signals  were detected,  which  is  in  agreement  with  MDR2  detection  in  the  P.  falciparum  proteomes  of  these stages.  The  fluorescence  signals  are  mainly  associated  with  hemozoin  granules  (in  both  asexual stages, gametocytes and ookinetes), which may suggest that this protein is located on the food vacuole membrane as P.  berghei trophozoites and gametocytes have many small food vacuoles. In  mature schizonts these food vacuoles merge into one or two large vesicles containing hemozoin, and  it  is  in  these  vesicles  that  we  also  observe  fluorescent  signal).  In  addition,    fluorescence signals were found associated with the plasma lemma of blood stages, which is especially  clear in  merozoites of mature schizonts. Fluorescence signals were also during oocyst development. From day 10 onwards,  before sporozoite formation,  a highly structured fluorescence pattern is observed within the oocyst  possibly associated with early sporoblast formation. In more mature oocysts,  when sporozoite formation is observed, the fluorescence signal becomes more diffuse but it is only  associated with the areas within the oocyst where sporozoites are present and are budding from the  sporoblasts.

Additional information

Other mutants
See the link multidrug resistance protein (mdr) for more MDR mutants
See also mutants RMgm-1165 and RMgm-1166 that lack expression of MDR2.


  Tagged: Mutant parasite with a tagged gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1311700
Gene Model P. falciparum ortholog PF3D7_1447900
Gene productmultidrug resistance protein 2 | ABC transporter B family member 2
Gene product: Alternative nameMDR2; ABCB2
Details of the genetic modification
Name of the tagmCherry-3xMyc
Details of taggingC-terminal
Additional remarks: tagging
Commercial source of tag-antibodies
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr/yfcu
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationFor the Pbmdr2::mCherry tagging construct, fragments at the 3’ region and the carboxy-terminal end of the coding sequence were amplified using specific primers. These fragments were cloned into the pBAT-SIL6 vector. The carboxy-terminus was cloned in frame with the mCherry-3xMyc tag.

The construct to tag the mdr gene contains a GFP expression cassette. In this cassette the gfp gene is under the control of the hsp70 promoter (see for more information on the basic plasmid pBAT-SIL6 the mutant RMgm-757).
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameGFP
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr/yfcu
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationFor the Pbmdr2::mCherry tagging construct, fragments at the 3’ region and the carboxy-terminal end of the coding sequence were amplified using specific primers. These fragments were cloned into the pBAT-SIL6 vector. The carboxy-terminus was cloned in frame with the mCherry-3xMyc tag.

The construct to tag the mdr gene contains a GFP expression cassette. In this cassette the gfp gene is under the control of the hsp70 promoter (see for more information on the basic plasmid pBAT-SIL6 the mutant RMgm-757).
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PBANKA_0711900
Gene Model P. falciparum ortholog PF3D7_0818900
Gene productheat shock protein 70
Gene product: Alternative nameHSP70
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_1340000
Gene productdihydrofolate synthase/folylpolyglutamate synthase, putative
Gene product: Alternative namePbDHFS-FPGS
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite PBANKA_1311700
Gene productmultidrug resistance protein 2; ABC transporter B family member 2
Gene product: Alternative nameMDR2; ABCB2
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4